Status:
COMPLETED
A Telephone-delievered Intervention to Reduce Methamphetamine Use
Lead Sponsor:
Turning Point
Collaborating Sponsors:
Eastern Health
Monash University
Conditions:
Methamphetamine Use Disorder
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
Australia has one of the highest rates of methamphetamine use in the world; however, uptake of face-to-face psychological treatment remains extremely low due to numerous individual (e.g. stigma, shame...
Eligibility Criteria
Inclusion
- Age 18+ years
- Mild or moderate methamphetamine use disorder (DSM-5 diagnosis confirmed at baseline assessment using the Structured Clinical Interview for DSM-5 Disorders - Research Version, SCID-5-RV)
- Used methamphetamine on at least two occasions in the past month
- Seeking to reduce methamphetamine use
- Able to provide informed consent, and comply with the requirements of the treatment protocol
- Willing to provide the contact details of their general practitioner or other treating physician, for follow-up
- English as a first language or fluent
- Educated to high school level (literacy)
- Regular access to a telephone
- Postal/email address to receive intervention materials
Exclusion
- Currently receiving treatment for substance use disorder (e.g. medically supervised detoxification, residential rehabilitation, drug counselling, pharmacotherapy - this criterion applies only at trial enrolment, and does not preclude the participant from entering treatment/receiving usual care during the trial)
- Requiring acute care for severe substance use disorder (DSM-5 diagnosis confirmed at baseline using the SCID-5-RV, with oversight from the Principal Investigator or Study Clinician)
- Requiring acute care for active suicidality or unstable psychiatric condition
- A diagnosed primary psychotic disorder (schizophrenia, schizoaffective disorder, bipolar disorder)
- Pregnancy
- Hearing impairment that would prohibit participation in telephone intervention / follow-up assessments
Key Trial Info
Start Date :
February 4 2021
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
January 25 2024
Estimated Enrollment :
204 Patients enrolled
Trial Details
Trial ID
NCT04713124
Start Date
February 4 2021
End Date
January 25 2024
Last Update
August 7 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Turning Point
Richmond, Victoria, Australia, 3121